المؤلفون: Vannier AGL; Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA., Dhungana A; Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA., Zhao F; Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA., Chen N; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Shubeck S; Department of Surgery, University of Chicago, Chicago, Illinois, USA., Hahn OM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Nanda R; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Jaskowiak NT; Department of Surgery, University of Chicago, Chicago, Illinois, USA., Fleming GF; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Olopade OI; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Pearson AT; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Huo D; Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA., Howard FM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.

المصدر: Cancer [Cancer] 2024 Apr 15; Vol. 130 (8), pp. 1210-1220. Date of Electronic Publication: 2023 Dec 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Receptor, ErbB-2*/genetics , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology, Humans ; Middle Aged ; Female ; Chemotherapy, Adjuvant ; Prognosis ; Combined Modality Therapy ; Neoplasm Recurrence, Local/pathology

المؤلفون: Freeman JQ; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois, USA., Khwaja A; Department of Medicine, The University of Chicago, Chicago, Illinois, USA., Zhao F; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois, USA., Nanda R; Department of Medicine, The University of Chicago, Chicago, Illinois, USA., Olopade OI; Department of Medicine, The University of Chicago, Chicago, Illinois, USA.; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois, USA., Huo D; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois, USA.; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois, USA.

المصدر: Telemedicine journal and e-health : the official journal of the American Telemedicine Association [Telemed J E Health] 2024 Mar; Vol. 30 (3), pp. 651-663. Date of Electronic Publication: 2023 Sep 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100959949 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-3669 (Electronic) Linking ISSN: 15305627 NLM ISO Abbreviation: Telemed J E Health Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/therapy , Breast Neoplasms*/diagnosis , COVID-19*/epidemiology , Telemedicine*, Female ; Humans ; Black or African American ; Healthcare Disparities ; Longitudinal Studies ; Pandemics ; Patient Satisfaction ; Personal Satisfaction ; White People ; Hispanic or Latino ; White

المؤلفون: Chen N; University of Chicago Medicine, Chicago, IL 60637, USA., Nanda R; University of Chicago Medicine, Chicago, IL 60637, USA. Electronic address: rnanda@bsd.uchicago.edu.

المصدر: The Lancet. Oncology [Lancet Oncol] 2024 Mar; Vol. 25 (3), pp. 269-270. Date of Electronic Publication: 2024 Feb 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics, Humans ; Female ; Receptors, Androgen/genetics ; Receptors, Estrogen

المؤلفون: Albain KS; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois., Yau C; University of California San Francisco, San Francisco, California., Petricoin EF; George Mason University, Fairfax, Virginia., Wolf DM; University of California San Francisco, San Francisco, California., Lang JE; Cleveland Clinic, Cleveland, Ohio., Chien AJ; University of California San Francisco, San Francisco, California., Haddad T; Mayo Clinic Rochester, Rochester, Minnesota., Forero-Torres A; University of Alabama at Birmingham, Birmingham, Alabama., Wallace AM; University of California San Diego, La Jolla, California., Kaplan H; Swedish Cancer Institute, Seattle, Washington., Pusztai L; Yale University, New Haven, Connecticut., Euhus D; Johns Hopkins University, Baltimore, Maryland., Nanda R; University of Chicago, Chicago, Illinois., Elias AD; University of Colorado Denver, Aurora, Colorado., Clark AS; University of Pennsylvania, Philadelphia, Pennsylvania., Godellas C; Loyola University Chicago Stritch School of Medicine, Maywood, Illinois., Boughey JC; Mayo Clinic Rochester, Rochester, Minnesota., Isaacs C; Georgetown University, Washington, District of Columbia., Tripathy D; University of Texas MD Anderson Cancer Center, Houston, Texas., Lu J; University of Southern California, Los Angeles, California., Yung RL; University of Washington, Seattle, Washington., Gallagher RI; George Mason University, Fairfax, Virginia., Wulfkuhle JD; George Mason University, Fairfax, Virginia., Brown-Swigart L; University of California San Francisco, San Francisco, California., Krings G; University of California San Francisco, San Francisco, California., Chen YY; University of California San Francisco, San Francisco, California., Potter DA; University of Minnesota, Minneapolis, Minnesota., Stringer-Reasor E; University of Alabama at Birmingham, Birmingham, Alabama., Blair S; University of California San Diego, La Jolla, California., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, California., Hirst GL; University of California San Francisco, San Francisco, California., Singhrao R; University of California San Francisco, San Francisco, California., Buxton M; University of California San Francisco, San Francisco, California., Clennell JL; University of California San Francisco, San Francisco, California., Sanil A; Berry Consultants, LLC, Houston, Texas., Berry S; Berry Consultants, LLC, Houston, Texas., Asare AL; Quantum Leap Healthcare Collaborative, San Francisco, California., Matthews JB; University of California San Francisco, San Francisco, California., DeMichele AM; University of Pennsylvania, Philadelphia, Pennsylvania., Hylton NM; University of California San Francisco, San Francisco, California., Melisko M; University of California San Francisco, San Francisco, California., Perlmutter J; Gemini Group, Ann Arbor, Michigan., Rugo HS; University of California San Francisco, San Francisco, California., Symmans WF; University of Texas MD Anderson Cancer Center, Houston, Texas., Van't Veer LJ; University of California San Francisco, San Francisco, California., Yee D; University of Minnesota, Minneapolis, Minnesota., Berry DA; Berry Consultants, LLC, Houston, Texas., Esserman LJ; University of California San Francisco, San Francisco, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 729-740.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Recombinant Fusion Proteins*, Female ; Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bayes Theorem ; Neoadjuvant Therapy ; Paclitaxel/adverse effects ; Receptor, ErbB-2/metabolism ; Receptor, TIE-2 ; Trastuzumab/adverse effects

المؤلفون: Kyalwazi B; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas., Yau C; Department of Surgery, University of California, San Francisco., Campbell MJ; Department of Surgery, University of California, San Francisco., Yoshimatsu TF; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Chien AJ; Department of Hematology Oncology and Surgery, University of California, San Francisco Helen Diller Comprehensive Cancer Center, San Francisco., Wallace AM; Division of Breast Surgery and the Comprehensive Breast Health Center, University of California San Diego, La Jolla., Forero-Torres A; Division of Hematology/Oncology, The University of Alabama at Birmingham., Pusztai L; Department of Medical Oncology, Yale School of Medicine, Yale University, New Haven, Connecticut., Ellis ED; Swedish Cancer Institute, Seattle, Washington., Albain KS; Division of Hematology-Oncology, Department of Medicine, University of Minnesota, Minneapolis., Blaes AH; Division of Hematology-Oncology, Department of Medicine, University of Minnesota, Minneapolis., Haley BB; Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas., Boughey JC; Department of Surgery, Mayo Clinic, Rochester, Minnesota., Elias AD; University of Colorado Cancer Center, Aurora., Clark AS; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia., Isaacs CJ; Department of Medicine, Georgetown University, Washington, DC., Nanda R; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Han HS; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida., Yung RL; Department of Medicine, School of Medicine, University of Washington, Seattle., Tripathy D; Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Edmiston KK; Inova Health System, Fairfax, Virginia., Viscusi RK; Department of Surgery, University of Arizona College of Medicine, Tucson., Northfelt DW; Department of Medical Oncology, Mayo Clinic, Phoenix, Arizona., Khan QJ; Division of Medical Oncology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, California., Hirst GL; Department of Surgery, University of California, San Francisco., Lu R; Quantum Leap Healthcare Collaborative, San Francisco, California., Symmans WF; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston., Yee D; Division of Hematology-Oncology, Department of Medicine, University of Minnesota, Minneapolis., DeMichele AM; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia., van 't Veer LJ; Department of Laboratory Medicine, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco., Esserman LJ; Department of Surgery, University of California, San Francisco., Olopade OI; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois.

المصدر: JAMA network open [JAMA Netw Open] 2023 Dec 01; Vol. 6 (12), pp. e2349646. Date of Electronic Publication: 2023 Dec 01.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Racial Groups*, Female ; Humans ; Retrospective Studies ; Transcriptome ; Pathologic Complete Response ; Disease-Free Survival

المؤلفون: Ren Z; Department of Radiology, The University of Chicago, Chicago, IL 60637, United States of America. Electronic address: zren1@uchicago.edu., Pineda FD; Department of Radiology, University of Pittsburgh, Pittsburgh, PA 15260, United States of America. Electronic address: fdp9@pitt.edu., Howard FM; Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637, United States of America. Electronic address: frederick.howard@uchospitals.edu., Fan X; Department of Radiology, The University of Chicago, Chicago, IL 60637, United States of America. Electronic address: xfan@uchicago.edu., Nanda R; Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637, United States of America. Electronic address: rnanda@medicine.bsd.uchicago.edu., Abe H; Department of Radiology, The University of Chicago, Chicago, IL 60637, United States of America. Electronic address: habe@radiology.bsd.uchicago.edu., Kulkarni K; Department of Radiology, The University of Chicago, Chicago, IL 60637, United States of America. Electronic address: kkulkarni@bsd.uchicago.edu., Karczmar GS; Department of Radiology, The University of Chicago, Chicago, IL 60637, United States of America. Electronic address: gskarczm@uchicago.edu.

المصدر: Magnetic resonance imaging [Magn Reson Imaging] 2023 Dec; Vol. 104, pp. 9-15. Date of Electronic Publication: 2023 Aug 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214883 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5894 (Electronic) Linking ISSN: 0730725X NLM ISO Abbreviation: Magn Reson Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/diagnostic imaging , Breast Neoplasms*/drug therapy , Neoadjuvant Therapy* , Magnetic Resonance Imaging*/methods , Contrast Media* , Receptor, ErbB-2*/metabolism, Humans ; Female ; Middle Aged ; Adult ; Treatment Outcome ; Aged ; Kinetics ; Sensitivity and Specificity

المؤلفون: Veeraraghavan J; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Gutierrez C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Pathology, Baylor College of Medicine, Houston, Texas., De Angelis C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Davis R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Wang T; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Pascual T; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain.; SOLTI Cancer Research Group, Barcelona, Spain., Selenica P; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, Manhattan, New York., Sanchez K; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Nitta H; Roche Tissue Diagnostics, Tucson, Arizona., Kapadia M; Roche Tissue Diagnostics, Tucson, Arizona., Pavlick AC; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Galvan P; SOLTI Cancer Research Group, Barcelona, Spain., Rexer B; Vanderbilt University, Nashville, Tennesse., Forero-Torres A; University of Alabama-Birmingham, Birmingham, Alabama., Nanda R; University of Chicago, Chicago, Illinois., Storniolo AM; Indiana University School of Medicine, Indianapolis, Indiana., Krop IE; Dana Farber Cancer Institute, Boston, Massachusetts., Goetz MP; Mayo Clinic, Rochester, Minnesota., Nangia JR; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Wolff AC; Johns Hopkins University, Baltimore, Maryland., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, Manhattan, New York., Reis-Filho JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, Manhattan, New York., Hilsenbeck SG; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain.; SOLTI Cancer Research Group, Barcelona, Spain., Osborne CK; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Rimawi MF; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 15; Vol. 29 (16), pp. 3101-3109.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/diagnosis , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics, Female ; Humans ; Antineoplastic Combined Chemotherapy Protocols ; Biomarkers, Tumor/metabolism ; Class I Phosphatidylinositol 3-Kinases/genetics ; Lapatinib ; Neoadjuvant Therapy ; Quinazolines ; Receptor, ErbB-2/metabolism ; Trastuzumab ; Treatment Outcome

المؤلفون: Terman E; Pritzker School of Medicine, The University of Chicago, Chicago, USA., Sheade J; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, USA., Zhao F; Department of Public Health Sciences, The University of Chicago, Chicago, USA., Howard FM; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, USA., Jaskowiak N; Department of Surgery, The University of Chicago, Chicago, USA., Tseng J; Department of Surgery, City of Hope Orange County, Irvine, USA., Chen N; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, USA., Hahn O; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, USA., Fleming G; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, USA., Huo D; Department of Public Health Sciences, The University of Chicago, Chicago, USA., Nanda R; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, USA. rnanda@medicine.bsd.uchicago.edu.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jul; Vol. 200 (1), pp. 75-83. Date of Electronic Publication: 2023 Apr 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/ethnology , Breast Neoplasms*/pathology , Racial Groups* , Age Factors*, Female ; Humans ; Black or African American ; Cohort Studies ; Neoadjuvant Therapy ; White ; Adult ; Middle Aged

المؤلفون: Magbanua MJM; University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: mark.magbanua@ucsf.edu., Brown Swigart L; University of California, San Francisco, San Francisco, CA 94143, USA., Ahmed Z; University of California, San Francisco, San Francisco, CA 94143, USA., Sayaman RW; University of California, San Francisco, San Francisco, CA 94143, USA., Renner D; Natera, Inc., Austin, TX 78753, USA., Kalashnikova E; Natera, Inc., Austin, TX 78753, USA., Hirst GL; University of California, San Francisco, San Francisco, CA 94143, USA., Yau C; University of California, San Francisco, San Francisco, CA 94143, USA., Wolf DM; University of California, San Francisco, San Francisco, CA 94143, USA., Li W; University of California, San Francisco, San Francisco, CA 94143, USA., Delson AL; UCSF Breast Science Advocacy Core, San Francisco, CA 94143, USA., Asare S; Quantum Leap Healthcare Collaborative, San Francisco, CA 94118, USA., Liu MC; Natera, Inc., Austin, TX 78753, USA; Mayo Clinic, Rochester, MN 55905, USA., Albain K; Loyola University Chicago, Maywood, IL 60153, USA., Chien AJ; University of California, San Francisco, San Francisco, CA 94143, USA., Forero-Torres A; University of Alabama at Birmingham, Birmingham, AL 35233, USA., Isaacs C; Georgetown University, Washington, DC 20007, USA., Nanda R; University of Chicago, Chicago, IL 60637, USA., Tripathy D; University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rodriguez A; Natera, Inc., Austin, TX 78753, USA., Sethi H; Natera, Inc., Austin, TX 78753, USA., Aleshin A; Natera, Inc., Austin, TX 78753, USA., Rabinowitz M; Natera, Inc., Austin, TX 78753, USA., Perlmutter J; UCSF Breast Science Advocacy Core, San Francisco, CA 94143, USA., Symmans WF; University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yee D; University of Minnesota, Minneapolis, MN 55455, USA., Hylton NM; University of California, San Francisco, San Francisco, CA 94143, USA., Esserman LJ; University of California, San Francisco, San Francisco, CA 94143, USA., DeMichele AM; University of Pennsylvania, Philadelphia, PA 19104, USA., Rugo HS; University of California, San Francisco, San Francisco, CA 94143, USA., van 't Veer LJ; University of California, San Francisco, San Francisco, CA 94143, USA.

المصدر: Cancer cell [Cancer Cell] 2023 Jun 12; Vol. 41 (6), pp. 1091-1102.e4. Date of Electronic Publication: 2023 May 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/genetics , Circulating Tumor DNA*/genetics, Humans ; Female ; Neoadjuvant Therapy ; Clinical Relevance ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biology ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism

المؤلفون: Miyashita M; The University of Chicago, Chicago, IL, USA., Bell JSK; Tempus Inc, Chicago, IL, USA., Wenric S; Tempus Inc, Chicago, IL, USA., Karaesmen E; Tempus Inc, Chicago, IL, USA., Rhead B; Tempus Inc, Chicago, IL, USA., Kase M; Tempus Inc, Chicago, IL, USA., Kaneva K; Tempus Inc, Chicago, IL, USA., De La Vega FM; Tempus Inc, Chicago, IL, USA., Zheng Y; The University of Chicago, Chicago, IL, USA., Yoshimatsu TF; The University of Chicago, Chicago, IL, USA., Khramtsova G; The University of Chicago, Chicago, IL, USA., Liu F; The University of Chicago, Chicago, IL, USA., Zhao F; The University of Chicago, Chicago, IL, USA., Howard FM; The University of Chicago, Chicago, IL, USA., Nanda R; The University of Chicago, Chicago, IL, USA., Beaubier N; Tempus Inc, Chicago, IL, USA., White KP; Tempus Inc, Chicago, IL, USA.; National University Singapore, Queenstown, Singapore., Huo D; The University of Chicago, Chicago, IL, USA., Olopade OI; The University of Chicago, Chicago, IL, USA. folopade@bsd.uchicago.edu.

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2023 May 25; Vol. 25 (1), pp. 58. Date of Electronic Publication: 2023 May 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/ethnology , Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/ethnology , Triple Negative Breast Neoplasms*/pathology, Female ; Humans ; Black People/genetics ; Mutation ; Precision Medicine ; White People